Related Experiment Videos
Probing studies on multiple dose effects of antide (Nal-Lys) GnRH antagonist in ovariectomized monkeys
J A Leal1, K Gordon, R F Williams
1Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk 23510.
Abstract:
This study was designed to extend evaluation of the long-acting effects of a "third generation" Antide (Nal-Lys) GnRH antagonist on gonadotropin secretion in ovariectomized (OVX) monkeys, with special attention to recrudescence of pituitary gonadotropin secretion after multiple dose treatments, as well as pituitary secretory responsiveness to GnRH. The duration of FSH/LH inhibition by Antide was dose-dependent, as well as being much longer than for Nal-Glu GnRHant; however, full recrudescence of gonadotropin secretion, albeit gradual, did occur. The acute LH secretory response to serial iv boluses of GnRH, in the face of GnRHant-induced suppression of gonadotropin secretion, was transiently accelerated and biologically active. Thereafter, the state of FSH/LH inhibition was resumed chronically. Thus, treatment with Antide produced profound long-term inhibition of tonic gonadotropin levels, yet hyper-responsiveness to exogenous GnRH administration was maintained throughout.
Insights
A novel GnRH antagonist, Antide, demonstrated long-lasting inhibition of gonadotropin secretion in monkeys. Pituitary responsiveness to GnRH was maintained, with gradual recovery of gonadotropin secretion after treatment.
Area of Science:
- Reproductive Endocrinology
- Neuroendocrinology
Background:
- Gonadotropin-releasing hormone (GnRH) antagonists are crucial for regulating reproductive hormones.
- Understanding the long-term effects and recovery patterns of novel GnRH antagonists is essential for clinical applications.
Purpose of the Study:
- To evaluate the long-acting effects of a third-generation GnRH antagonist, Antide (Nal-Lys), on gonadotropin secretion in ovariectomized (OVX) monkeys.
- To investigate the recrudescence of pituitary gonadotropin secretion and responsiveness to GnRH following multiple Antide doses.
Main Methods:
- Ovariectomized monkeys received multiple doses of Antide.
- Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels were monitored.
- Pituitary responsiveness to exogenous GnRH administration was assessed.
Main Results:
- Antide exhibited dose-dependent and prolonged inhibition of FSH and LH secretion compared to a previous GnRH antagonist.
- Full, albeit gradual, recrudescence of gonadotropin secretion was observed after treatment.
- Despite GnRH antagonist-induced suppression, acute LH secretory responses to GnRH were transiently accelerated and biologically active.
Conclusions:
- Antide provides profound, long-term inhibition of tonic gonadotropin levels.
- Pituitary secretory hyper-responsiveness to exogenous GnRH is maintained during Antide treatment.
- This suggests a potential for controlled hormonal modulation in reproductive endocrine disorders.